Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria

The issue of rapid phenotypic drug sensitivity testing of clinical isolates of tuberculous mycobacteria remains relevant.The objective of the study is to develop a new test system for rapid phenotypic drug sensitivity testing of MTB clinical isolates based on lytic mycobacteriophages, capable of tes...

Full description

Saved in:
Bibliographic Details
Main Authors: M. B. Lapenkova, G. A. Аrustamova, Yu. S. Аlyapkina, P. N. Filippov, S. V. Lazebny, M. A. Vladimirskiy
Format: Article
Language:Russian
Published: New Terra Publishing House 2020-09-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1448
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850282820053762048
author M. B. Lapenkova
G. A. Аrustamova
Yu. S. Аlyapkina
P. N. Filippov
S. V. Lazebny
M. A. Vladimirskiy
author_facet M. B. Lapenkova
G. A. Аrustamova
Yu. S. Аlyapkina
P. N. Filippov
S. V. Lazebny
M. A. Vladimirskiy
author_sort M. B. Lapenkova
collection DOAJ
description The issue of rapid phenotypic drug sensitivity testing of clinical isolates of tuberculous mycobacteria remains relevant.The objective of the study is to develop a new test system for rapid phenotypic drug sensitivity testing of MTB clinical isolates based on lytic mycobacteriophages, capable of testing resistance to first and second line drugs.Subjects and methods. Cultures of MTB (108 clinical isolates after primary culturing in Bactec MGIT) were incubated for 48 hours with addition of anti-tuberculosis drugs, then for 48 hours more after adding lytic mycobateriophage D29. The subsequent multiplex reaction of the polymerase chain reaction in real time allowed performing quantitative analysis of MTB DNA and mycobacteriophage DNA. The drug sensitivity of the tested sample was assessed by ranges of the differences in fluorescence threshold levels corresponding to the amount of mycobacteriophages between the control and test sample. At the same time, the drug sensitivity/resistance of all MTB clinical isolates after repeated culture was tested by Bactec MGIT which was adopted as a reference method.Results. Lytic mycobacteriophage-based drug sensitivity testing of 108 MTB isolated to four first line drugs and 90 isolates to six second line anti-tuberculosis drugs demonstrated a high level of concordance with the results of the Bactec MGIT system. It provided 99.5% sensitivity and 100% specificity of the method for 3 first-line drugs; it was slightly lower for ethambutol (86 and 96.9%, respectively), while for second line drugs, its sensitivity made 94.83% and specificity - 98.85%.
format Article
id doaj-art-e70a38775479462ab922ee5c10d8c194
institution OA Journals
issn 2075-1230
2542-1506
language Russian
publishDate 2020-09-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-e70a38775479462ab922ee5c10d8c1942025-08-20T01:47:52ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062020-09-01988142210.21292/2075-1230-2020-98-8-14-221447Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteriaM. B. Lapenkova0G. A. Аrustamova1Yu. S. Аlyapkina2P. N. Filippov3S. V. Lazebny4M. A. Vladimirskiy5National Medical Research Center of Phthisiopulmonology and Infectious DiseasesNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesMoscow Regional Clinical TB DispensaryMoscow Regional Clinical TB DispensaryNational Medical Research Center of Phthisiopulmonology and Infectious DiseasesThe issue of rapid phenotypic drug sensitivity testing of clinical isolates of tuberculous mycobacteria remains relevant.The objective of the study is to develop a new test system for rapid phenotypic drug sensitivity testing of MTB clinical isolates based on lytic mycobacteriophages, capable of testing resistance to first and second line drugs.Subjects and methods. Cultures of MTB (108 clinical isolates after primary culturing in Bactec MGIT) were incubated for 48 hours with addition of anti-tuberculosis drugs, then for 48 hours more after adding lytic mycobateriophage D29. The subsequent multiplex reaction of the polymerase chain reaction in real time allowed performing quantitative analysis of MTB DNA and mycobacteriophage DNA. The drug sensitivity of the tested sample was assessed by ranges of the differences in fluorescence threshold levels corresponding to the amount of mycobacteriophages between the control and test sample. At the same time, the drug sensitivity/resistance of all MTB clinical isolates after repeated culture was tested by Bactec MGIT which was adopted as a reference method.Results. Lytic mycobacteriophage-based drug sensitivity testing of 108 MTB isolated to four first line drugs and 90 isolates to six second line anti-tuberculosis drugs demonstrated a high level of concordance with the results of the Bactec MGIT system. It provided 99.5% sensitivity and 100% specificity of the method for 3 first-line drugs; it was slightly lower for ethambutol (86 and 96.9%, respectively), while for second line drugs, its sensitivity made 94.83% and specificity - 98.85%.https://www.tibl-journal.com/jour/article/view/1448tuberculous mycobacteriadrug sensitivitymycobacteriophagepolymerase chain reaction
spellingShingle M. B. Lapenkova
G. A. Аrustamova
Yu. S. Аlyapkina
P. N. Filippov
S. V. Lazebny
M. A. Vladimirskiy
Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
Туберкулез и болезни лёгких
tuberculous mycobacteria
drug sensitivity
mycobacteriophage
polymerase chain reaction
title Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
title_full Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
title_fullStr Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
title_full_unstemmed Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
title_short Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
title_sort mycobacteriophage based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
topic tuberculous mycobacteria
drug sensitivity
mycobacteriophage
polymerase chain reaction
url https://www.tibl-journal.com/jour/article/view/1448
work_keys_str_mv AT mblapenkova mycobacteriophagebasedtestsystemforphenotypicdrugsensitivityofclinicalisolatesoftuberculousmycobacteria
AT gaarustamova mycobacteriophagebasedtestsystemforphenotypicdrugsensitivityofclinicalisolatesoftuberculousmycobacteria
AT yusalyapkina mycobacteriophagebasedtestsystemforphenotypicdrugsensitivityofclinicalisolatesoftuberculousmycobacteria
AT pnfilippov mycobacteriophagebasedtestsystemforphenotypicdrugsensitivityofclinicalisolatesoftuberculousmycobacteria
AT svlazebny mycobacteriophagebasedtestsystemforphenotypicdrugsensitivityofclinicalisolatesoftuberculousmycobacteria
AT mavladimirskiy mycobacteriophagebasedtestsystemforphenotypicdrugsensitivityofclinicalisolatesoftuberculousmycobacteria